• Home >
  • Sector

    • Small Molecule

    Traditional, chemically synthesized drugs (typically oral solid dose products) continue to be the dominant drug delivery form, used for a wide range of treatments. Here you will find content about formulations and the manufacturing technology and techniques used to make these popular products

    Articles

    Screen Shot 2023 09 06 At 11 17 20 Am
    Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
    Shutterstock 2224667693
    Bright ideas are helping drugs and butterflies take flight
    Microsoft Teams Image (1)
    In phase 2 of our OSD series, we cover the resurgence of fixed-dose combinations and the pursuit of effective oral delivery for biologics
    Microsoft Teams Image (2)
    In phase III of our OSD series, we cover what's on the horizon for the digital metamorphosis of drug delivery, including 3D printing and robot pills.
    Pm2303 Hero 854x480 Web
    There is no rest for reproductive health drugs in post-Roe America

    News

    PM2205-HERO-575x327-Operations-copy
    How pharma manufacturers can best protect equipment from corrosion
    PM2205-HERO-575x327-CoverStory2
    Can policy reform save a market in peril?
    PM2202-HERO-575x327-Development-copy
    New methods and strategies to address the complexities of viral infection offer hope for antiviral drug development
    PM2112-HERO-575x327-CoverStory
    As holes in mental health treatment deepen, can pharma fill the voids?
    PM20XX-HERO-575x327-1Article
    At some point, the patent cliff claims the high-rolling life of market exclusivity for all drugs — and 2021 is, of course, no exception.Although the industry has been flushed ...
    PM2104-HERO-880x500-Operations
    How an objective assessment of equipment’s efficiency can make a big difference
    PM2104-HERO-575x327-Pipeline
    It’s no secret that the pipeline for Alzheimer’s treatments has mostly become a sinkhole for dozens of failed drugs and billions in lost R&D dollars. But with the stakes so high...